Revealed: Insights into the Evolving Desmoid Tumors Market by 2035
The Desmoid Tumors Market is on a promising trajectory, with projections indicating a compound annual growth rate (CAGR) of 5.76% leading up to 2035. As this niche segment of oncology evolves, it is expected to grow substantially, reaching a market size of USD 7.628 billion. The rising incidence of desmoid tumors, coupled with advancements in treatment paradigms, drives this upward trend....
0 Comments 0 Shares 66 Views 0 Reviews